Moderna Inc. (MRNA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Moderna Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$214.16
+2.98% today
Market cap
$83.0B
Overall quality
—
Kronos AI 30-day
−55.9%
0 of 8 simulated paths end higher
Moderna Inc. (MRNA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $83.0B. It trades at $214.16, up 2.98% today. 20 analysts' average target of $127.69 implies −40.4% from today's price. Kronos AI's 30-day forecast is −55.9% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $127.69 |
| Low – high | $45.00 – $230.00 |
| Analysts | 20 |
| Upside to average | −40.4% |
Kronos AI 30-day forecast
| Expected close | $91.76 (−55.9%) |
| Likely range | −85.2% … −36.1% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.